Aidoc has raised a $150.0M Series E, with Goldman Sachs Alternatives' Growth Equity arm providing the capital.
The company builds clinical AI that runs in the background of hospital workflows, analyzing medical data to flag critical information for care teams when they need it. Its technology is built on what Aidoc calls aiOS, a platform designed to aggregate data across systems and prompt collective action rather than leaving insights stranded in silos.








.png&w=3840&q=75)







